In addition, our results showed that the Let-7 target genes (HMGA2, IGF2BP2, and LIN28B) were significantly upregulated in glioblastoma patient-derived cells (GBM04T) after anti-Let-7 treatment (Supplementary Figure S1). The gene discussed is IGF2BP2; the disease is glioblastoma.